Effect of BCG in treatment of diabetes type 1

Phase 2

Recruiting

• Conditions: Diabetes type1.; Type 1 diabetes mellitus with ketoacidosis; E10.1

• Registration Number: IRCT20201012049003N1
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

HbA1C>7
Get the full dose of insulin
having diabetes for at least 1 year (to pass the Honeymoon course)
Age category 6 to 14 years

Exclusion Criteria

retinopathy
Nephropathy
Diabetic neuropathy
Macrovascular complications of diabetes
HbA1C<7
New cases of type 1 diabetes
Having a recurrent infection or a history of allergy to the vaccine at birth
Take high doses of corticosteroids
History of immunodeficiency disease
celiac

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c level in patients. Timepoint: Measurement of HbA1c at the beginning of the study and 3, 6, 9, and 12 months after the first vaccine was given. Method of measurement: blood test.